Table 5.
Univariate Analysis Of Predictors For Poor Prognosis In The MRSA Group
| Variable | No. (%) Of Patients | P-value | |
|---|---|---|---|
| Poor Prognosis (69) | Good Prognosis (182) | ||
| Demographic | |||
| Age, year, mean±SD | 50.52±17.06 | 47.90±15.55 | 0.246 |
| Male sex | 45 (65.2) | 131 (72.0) | 0.296 |
| Underlying disease | |||
| Diabetes mellitus | 11 (15.9) | 26 (14.3) | 0.741 |
| Malignancy | 12 (17.4) | 18 (9.9) | 0.102 |
| Inflammatory disease | 7 (10.1) | 20 (11.0) | 0.847 |
| Hypertension | 10 (14.5) | 22 (12.1) | 0.610 |
| Renal insufficiency | 11 (15.9) | 11 (6.0) | 0.013 |
| Cardiac insufficiency | 10 (14.5) | 18 (9.9) | 0.301 |
| Tuberculosis | 2 (2.9) | 3 (1.6) | 0.899 |
| Hematopathy | 1 (1.4) | 2 (1.1) | 1.000 |
| Unhealth lifestyle | |||
| Smoking history | 18 (26.1) | 60 (33.0) | 0.293 |
| Alcohol abuse | 7 (10.1) | 14 (7.7) | 0.531 |
| Invasive procedure | |||
| Endoscopic therapy | 4 (5.8) | 4 (2.2) | 0.295 |
| Presence of a Foley catheter | 42 (60.9) | 99 (54.4) | 0.356 |
| Presence of central venous catheters | 18 (26.1) | 25 (13.7) | 0.020 |
| Insertion of gastric tube | 11 (15.9) | 13 (7.1) | 0.034 |
| Tracheotomy | 9 (13.0) | 22 (12.1) | 0.837 |
| Sputum suction | 18 (26.1) | 33 (18.1) | 0.162 |
| Antibiotic use | |||
| Empirical use of antibiotics | 36 (52.2) | 122 (67.0) | 0.030 |
| Use antibiotics based on drug susceptibility test | 48 (69.6) | 118 (64.8) | 0.480 |
| Antibiotic us more than 15 days | 28 (40.6) | 77 (42.3) | 0.804 |
| Blood examination | |||
| Serum albumin | |||
| <35 g/L | 41 (59.4) | 91 (50.0) | 0.182 |
| (35–51)g/L | 26 (37.7) | 88 (48.4) | 0.130 |
| >51 g/L | 2 (2.9) | 3 (1.6) | 0.899 |
| White blood cell | |||
| <4.0×10^9/L | 2(2.9) | 13(7.1) | 0.333 |
| (4.0–10.0)×10^9/L | 8(11.6) | 19(10.4) | 0.792 |
| >10.0×10^9/L | 59 (85.5) | 150 (82.4) | 0.558 |
| Others | |||
| Receipt of immunosuppressors | 12 (17.4) | 12 (6.6) | 0.009 |
| Surgery | 54 (78.3) | 124 (68.1) | 0.115 |
| Total hospital stays more than 30 days | 31 (44.9) | 83 (45.6) | 0.923 |
| Chemotherapy | 5(7.2) | 13 (7.1) | 0.977 |
| Radiotherapy | 4 (5.8) | 9 (4.9) | 1.000 |
| Admission to ICU | 17 (24.6) | 36 (19.8) | 0.400 |
| Infection type | |||
| Wound and soft tissue infections | 37 (53.6) | 119 (64.8) | 0.103 |
| Respiratory tract infection | 18 (26.1) | 33 (18.1) | 0.162 |
| Bloodstream infection | 7 (10.1) | 17 (9.3) | 0.847 |
| Intra-abdominal infection | 5 (7.2) | 3 (1.6) | 0.064 |
| Others | 1 (1.4) | 12 (6.6) | 0.186 |
Abbreviation: MRSA, methicillin-resistant Staphylococcus aureus.